---
$id: https://graph.org.ai/products/commodity/51101641
$type: Product
source: UNSPSC
code: "51101641"
title: "Buparvaquone"
class: "51101600"
classTitle: "Amebicides and trichomonacides"
family: "51100000"
familyTitle: "Amebicides and trichomonacides and antiprotozoals"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Buparvaquone

**UNSPSC Code**: 51101641
**Class**: [Amebicides and trichomonacides](Amebicides and trichomonacides.mdx)
**Family**: [Amebicides and trichomonacides and antiprotozoals](../Amebicides and trichomonacides and antiprotozoals.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an antiprotozoal agent with the molecular formula C21H26O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 0354RT7LG4, chemically known as 1,4-naphthalenedione, 2-((4-(1,1-dimethylethyl)cyclohexyl)methyl)-3-hydroxy- but generally known as buparvaquone, which bears US NIH Compound Identifier 71768. European Medicines Agency schedules Buparvaquone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05980MIG. The term BUPARVAQUONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 38, No. 6, 1984, List 24). BUPARVAQUONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule buparvaquone under HS 29146990 and SITC 51629. As of Q4 2014, BUPARVAQUONE remains the US FDA Preferred Term for this commodity. Buparvaquone bears US NLM identifiers UMLS ID C0054224 and NCI Concept Code C73276. SMILES: OC1=C(CC2CCC(C(C)(C)C)CC2)C(=O)C(=O)C2C1CCCC2.

